Latest News about Market/Moving Exclusives
Recent news which mentions Market/Moving Exclusives
From Benzinga
From Benzinga
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
May 13, 2025
From Benzinga
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
May 12, 2025
From Benzinga
EXCLUSIVE: DeFi Development Makes Record Solana Purchase, Surpasses $100 Million In Treasury Holdings
May 12, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Aduro's Deal With Cleanfarms Targets Farm Plastic Recycling Revolution And Scalable Sustainability
May 08, 2025
From Benzinga
EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program
May 07, 2025
From Benzinga
EXCLUSIVE: DeFi Development Corp Expands Digital Asset Portfolio, Holds $58.5 Million In Solana Tokens
May 06, 2025
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
May 06, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
May 05, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.